Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge. Explore Teva Pharmaceutical Indus stock price, quotes, charts and forecasts with Benzinga. Stay updated on ...

SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a company developing and deploying transportation safety and advanced driver-assistance systems (ADAS) technologies and solutions, today presented its ...

Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...

In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel ...

Around the same time, the prototype of the Squibb logo was designed ... and 6 products at the "full development" stage, meaning they are in late-stage clinical development or have been submitted ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Pre-Market: 7:00:00 a.m. EDT Loading Chart for TEVA ...